CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 163 filers reported holding CLOVIS ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $137,000 | -73.6% | 115,299 | -55.1% | 0.00% | -80.0% |
Q1 2022 | $519,000 | -36.2% | 256,919 | -14.4% | 0.01% | -52.4% |
Q4 2021 | $814,000 | -1.3% | 300,203 | +62.4% | 0.02% | +40.0% |
Q3 2021 | $825,000 | +1.6% | 184,904 | +59.9% | 0.02% | +7.1% |
Q1 2021 | $812,000 | +374.9% | 115,628 | +294.6% | 0.01% | +180.0% |
Q3 2020 | $171,000 | -13.6% | 29,300 | 0.0% | 0.01% | -44.4% |
Q2 2020 | $198,000 | – | 29,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |